General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy.
Toshifumi TadaMasayuki KurosakiNobuharu TamakiYutaka YasuiNami MoriKeiji TsujiChitomi HasebeKoji JokoTakehiro AkahaneKoichiro FurutaHaruhiko KobashiHideki FujiiToru IshiiHiroyuki MarusawaMasahiko KondoYuji KojimaHideo YoshidaYasushi UchidaShinichiro NakamuraNamiki IzumiPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
GES is useful for predicting HCC development in patients with advanced liver fibrosis after SVR.